{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:53:19Z","timestamp":1781578399279,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02461-9","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:47:40Z","timestamp":1781578060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["WTAP-mediated m6A methylation of CEP55 promotes immune evasion in lung adenocarcinoma by activating the PI3K\/AKT\/mTOR pathway"],"prefix":"10.1007","volume":"301","author":[{"given":"Tianyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3620-3330","authenticated-orcid":false,"given":"Ran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"1","key":"2461_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H (2022) The role of m6A RNA methylation in cancer metabolism. Mol Cancer 21(1):14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4","journal-title":"Mol Cancer"},{"issue":"3","key":"2461_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2461_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-022-01549-1","volume":"21","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lu Z, Qi C, Yu C, Li Y, Huan W, Wang R, Luo W, Shen D, Ding L, Ren L, Xie H, Xue D, Wang M, Ni K, Xia L, Qian J, Li G (2022) N(6)-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Mol Cancer 21(1):111. https:\/\/doi.org\/10.1186\/s12943-022-01549-1","journal-title":"Mol Cancer"},{"key":"2461_CR4","doi-asserted-by":"publisher","unstructured":"Fan Y, Li X, Sun H, Gao Z, Zhu Z, Yuan K (2022) Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential. Biomolecules 12(9). https:\/\/doi.org\/10.3390\/biom12091224","DOI":"10.3390\/biom12091224"},{"issue":"1","key":"2461_CR5","doi-asserted-by":"publisher","first-page":"e13340","DOI":"10.1111\/cpr.13340","volume":"56","author":"H Feng","year":"2023","unstructured":"Feng H, Yuan X, Wu S, Yuan Y, Cui L, Lin D, Peng X, Liu X, Wang F (2023) Effects of writers, erasers and readers within miRNA-related m6A modification in cancers. Cell Prolif 56(1):e13340. https:\/\/doi.org\/10.1111\/cpr.13340","journal-title":"Cell Prolif"},{"issue":"2","key":"2461_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s12013-024-01592-3","volume":"83","author":"R Geng","year":"2025","unstructured":"Geng R, Ren M, Ma Y, Su W (2025) Mechanism of the KIAA1429\/KLF1\/PD-L1 Axis in Regulating Immune Escape in Non-small Cell Lung Cancer. Cell Biochem Biophys 83(2):1835\u20131845. https:\/\/doi.org\/10.1007\/s12013-024-01592-3","journal-title":"Cell Biochem Biophys"},{"key":"2461_CR7","doi-asserted-by":"publisher","first-page":"1156177","DOI":"10.3389\/fonc.2023.1156177","volume":"13","author":"M Huang","year":"2023","unstructured":"Huang M, Zhong F, Chen M, Hong L, Chen W, Abudukeremu X, She F, Chen Y (2023) CEP55 as a promising biomarker and therapeutic target on gallbladder cancer. Front Oncol 13:1156177. https:\/\/doi.org\/10.3389\/fonc.2023.1156177","journal-title":"Front Oncol"},{"issue":"6","key":"2461_CR8","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.21037\/tcr-23-2295","volume":"13","author":"HR Jia","year":"2024","unstructured":"Jia HR, Li WC, Wu L (2024) The prognostic value of immune escape-related genes in lung adenocarcinoma. Transl Cancer Res 13(6):2647\u20132661. https:\/\/doi.org\/10.21037\/tcr-23-2295","journal-title":"Transl Cancer Res"},{"key":"2461_CR9","doi-asserted-by":"publisher","first-page":"1323344","DOI":"10.3389\/fmed.2023.1323344","volume":"10","author":"H Jiang","year":"2023","unstructured":"Jiang H, Bu L (2023) Progress in the treatment of lung adenocarcinoma by integrated traditional Chinese and Western medicine. Front Med (Lausanne) 10:1323344. https:\/\/doi.org\/10.3389\/fmed.2023.1323344","journal-title":"Front Med (Lausanne)"},{"key":"2461_CR10","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.tranon.2024.101934","volume":"45","author":"C Jin","year":"2024","unstructured":"Jin C, Gao J, Zhu J, Ao Y, Shi B, Li X (2024) Exosomal NAT10 from esophageal squamous cell carcinoma cells modulates macrophage lipid metabolism and polarization through ac4C modification of FASN. Transl Oncol 45:101934. https:\/\/doi.org\/10.1016\/j.tranon.2024.101934","journal-title":"Transl Oncol"},{"key":"2461_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.06.007","volume":"518","author":"V Koh","year":"2021","unstructured":"Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins JA, Ito Y, Wang J, Helmrath MA, Merchant JL, Ahmed SA, Shabbir A, Yan So JB, Yong WP, Zavros Y (2021) Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids. Cancer Lett 518:59\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.007","journal-title":"Cancer Lett"},{"issue":"1","key":"2461_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-022-01558-0","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Ma S, Deng Y, Yi P, Yu J (2022a) Targeting the RNA m(6)A modification for cancer immunotherapy. Mol Cancer 21(1):76. https:\/\/doi.org\/10.1186\/s12943-022-01558-0","journal-title":"Mol Cancer"},{"issue":"6","key":"2461_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41418-021-00905-w","volume":"29","author":"ZX Li","year":"2022","unstructured":"Li ZX, Zheng ZQ, Yang PY, Lin L, Zhou GQ, Lv JW, Zhang LL, Chen F, Li YQ, Wu CF, Li F, Ma J, Liu N, Sun Y (2022b) WTAP-mediated m(6)A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis. Cell Death Differ 29(6):1137\u20131151. https:\/\/doi.org\/10.1038\/s41418-021-00905-w","journal-title":"Cell Death Differ"},{"issue":"1","key":"2461_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41467-024-45340-w","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Jiang M, Aye L, Luo L, Zhang Y, Xu F, Wei Y, Peng D, He X, Gu J, Yu X, Li G, Ge D, Lu C (2024) UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment. Nat Commun 15(1):1200. https:\/\/doi.org\/10.1038\/s41467-024-45340-w","journal-title":"Nat Commun"},{"issue":"3","key":"2461_CR12","doi-asserted-by":"publisher","first-page":"101399","DOI":"10.1016\/j.gendis.2024.101399","volume":"12","author":"J Li","year":"2025","unstructured":"Li J, Zhang Y, Deng J, Weng S, Xu H, Ba Y, Zuo A, Liu S, Cheng Q, Zhang J, Luo P, Li Z, Han X, Liu Z (2025) Cross-talk between lactate metabolism and immunity reveals CEP55 as a potential regulator in the immunosuppressive microenvironment of hepatocellular carcinoma. Genes Dis 12(3):101399. https:\/\/doi.org\/10.1016\/j.gendis.2024.101399","journal-title":"Genes Dis"},{"issue":"1","key":"2461_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, Dong C, Chen C, Zhou Y (2021) N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer 20(1):105. https:\/\/doi.org\/10.1186\/s12943-021-01398-4","journal-title":"Mol Cancer"},{"issue":"1","key":"2461_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12885-026-15566-6","volume":"26","author":"X Liu","year":"2026","unstructured":"Liu X, Li S, Zhou M, Ding N, Chen J, Zhou N (2026) M6A modification-related genes characterize prognostic risk and immune regulation in lung adenocarcinoma. BMC Cancer 26(1):226. https:\/\/doi.org\/10.1186\/s12885-026-15566-6","journal-title":"BMC Cancer"},{"key":"2461_CR18","doi-asserted-by":"publisher","first-page":"774103","DOI":"10.3389\/fimmu.2021.774103","volume":"12","author":"S Mafi","year":"2021","unstructured":"Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, Rostamzadeh D (2021) mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment. Front Immunol 12:774103. https:\/\/doi.org\/10.3389\/fimmu.2021.774103","journal-title":"Front Immunol"},{"issue":"1","key":"2461_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41598-023-50938-z","volume":"14","author":"Y Pengjie","year":"2024","unstructured":"Pengjie Y, Rong J, Pengfei N (2024) miR-378a-5p exerts tumor-suppressive effects on esophageal squamous cell carcinoma after neoadjuvant immunotherapy by downregulating APOC1\/CEP55. Sci Rep 14(1):305. https:\/\/doi.org\/10.1038\/s41598-023-50938-z","journal-title":"Sci Rep"},{"key":"2461_CR20","doi-asserted-by":"publisher","unstructured":"Shurin MR, Umansky V (2022) Cross-talk between HIF and PD-1\/PD-L1 pathways in carcinogenesis and therapy. J Clin Invest 132(9). https:\/\/doi.org\/10.1172\/JCI159473","DOI":"10.1172\/JCI159473"},{"key":"2461_CR21","doi-asserted-by":"publisher","unstructured":"Siddique F, Shehata M, Ghazal M, Contractor S, El-Baz A (2024) Lung Cancer Subtyping: A Short Review. Cancers (Basel) 16(15). https:\/\/doi.org\/10.3390\/cancers16152643","DOI":"10.3390\/cancers16152643"},{"issue":"4","key":"2461_CR22","doi-asserted-by":"publisher","first-page":"11240","DOI":"10.1080\/21655979.2022.2064205","volume":"13","author":"L Song","year":"2022","unstructured":"Song L, Liu S, Zhao S (2022) Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT)\/mammalian target of rapamycin (mTOR)\/S6 kinase 1 (S6K1) pathway. Bioengineered 13(4):11240\u201311257. https:\/\/doi.org\/10.1080\/21655979.2022.2064205","journal-title":"Bioengineered"},{"issue":"9","key":"2461_CR23","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41417-024-00791-7","volume":"31","author":"X Sun","year":"2024","unstructured":"Sun X, Wang H, Pu X, Wu Y, Yuan X, Wang X, Lu H (2024) Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification. Cancer Gene Ther 31(9):1315\u20131322. https:\/\/doi.org\/10.1038\/s41417-024-00791-7","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"2461_CR24","doi-asserted-by":"publisher","first-page":"151086","DOI":"10.1016\/j.ejcb.2020.151086","volume":"99","author":"D Tandon","year":"2020","unstructured":"Tandon D, Banerjee M (2020) Centrosomal protein 55: A new paradigm in tumorigenesis. Eur J Cell Biol 99(5):151086. https:\/\/doi.org\/10.1016\/j.ejcb.2020.151086","journal-title":"Eur J Cell Biol"},{"issue":"10","key":"2461_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/cac2.70052","volume":"45","author":"F Tian","year":"2025","unstructured":"Tian F, Huang J, Fan W, Li X, Zhan Y, Zhu K, Wang X, Hong X, Wang X, Ren J, Xing Y, Cai L (2025) m(6)A-modified EHD1 controls PD-L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma. Cancer Commun (Lond) 45(10):1285\u20131308. https:\/\/doi.org\/10.1002\/cac2.70052","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"2461_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-024-03120-w","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang B, Wang Y, Wang W, Wang Z, Zhang Y, Pan X, Wen X, Leng H, Guo J, Ma XX (2024) WTAP\/IGF2BP3 mediated m6A modification of the EGR1\/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells. J Exp Clin Cancer Res 43(1):204. https:\/\/doi.org\/10.1186\/s13046-024-03120-w","journal-title":"J Exp Clin Cancer Res"},{"key":"2461_CR27","doi-asserted-by":"publisher","first-page":"102685","DOI":"10.1016\/j.tranon.2026.102685","volume":"65","author":"Z Wang","year":"2026","unstructured":"Wang Z, Liu H, Liang J, Zhang Y, Cho WC, Ye M, Ma D, Kong M, Zhu C, Shen J (2026) Ferroptosis induction enhances anti-PD-1 efficacy in NSCLC via HIF-1alpha\/PD-L1 modulation. Transl Oncol 65:102685. https:\/\/doi.org\/10.1016\/j.tranon.2026.102685","journal-title":"Transl Oncol"},{"issue":"8","key":"2461_CR28","doi-asserted-by":"publisher","first-page":"e70535","DOI":"10.1096\/fj.202402990R","volume":"39","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ye M, Yu P, Hu P, Xue B, He N, Ding Y, Yan L, Bai J, Tang Q (2025) CEP55, A Promising Prognostic Biomarker for Pancreatic Neuroendocrine Neoplasms, Promotes Tumor Progression Through Activation of PI3K\/AKT\/mTOR Pathway. FASEB J 39(8):e70535. https:\/\/doi.org\/10.1096\/fj.202402990R","journal-title":"FASEB J"},{"key":"2461_CR29","doi-asserted-by":"publisher","unstructured":"Yan SM, Liu L, Gu WY, Huang LY, Yang Y, Huang YH, Luo RZ (2021) CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis. J Oncol 2021: 8890715. https:\/\/doi.org\/10.1155\/2021\/8890715","DOI":"10.1155\/2021\/8890715"},{"key":"2461_CR30","doi-asserted-by":"publisher","first-page":"104861","DOI":"10.1016\/j.critrevonc.2025.104861","volume":"214","author":"Y Yao","year":"2025","unstructured":"Yao Y, Tao G, Xie D, Xu Y, Li L (2025) Effect of JAK\/STAT signaling on anti-PD-L1 immunotherapy efficacy in lung cancer. Crit Rev Oncol Hematol 214:104861. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104861","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2461_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","volume":"14","author":"M Yi","year":"2021","unstructured":"Yi M, Niu M, Xu L, Luo S, Wu K (2021) Regulation of PD-L1 expression in the tumor microenvironment. J Hematol Oncol 14(1):10. https:\/\/doi.org\/10.1186\/s13045-020-01027-5","journal-title":"J Hematol Oncol"},{"issue":"45","key":"2461_CR33","doi-asserted-by":"publisher","first-page":"e31195","DOI":"10.1097\/MD.0000000000031195","volume":"101","author":"X Zhang","year":"2022","unstructured":"Zhang X, Cai X (2022) Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma. Med (Baltim) 101(45):e31195. https:\/\/doi.org\/10.1097\/MD.0000000000031195","journal-title":"Med (Baltim)"},{"issue":"19","key":"2461_CR32","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.21037\/atm-21-3825","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang H, Dong W, Zhao H, Zeng Z, Zhang F, Hu Y, Li Q, Chen J, Meng E, Xiao W (2021) Homozygous deletion of the HLA-B gene as an acquired-resistance mechanism to nivolumab in a patient with lung adenocarcinoma: a case report. Ann Transl Med 9(19):1506. https:\/\/doi.org\/10.21037\/atm-21-3825","journal-title":"Ann Transl Med"},{"issue":"7","key":"2461_CR34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11010-022-04607-w","volume":"478","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu Q, Li E, Shi T, Chen H (2023) CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling. Mol Cell Biochem 478(7):1561\u20131571. https:\/\/doi.org\/10.1007\/s11010-022-04607-w","journal-title":"Mol Cell Biochem"},{"key":"2461_CR36","doi-asserted-by":"publisher","unstructured":"Zhou W, Xian Q, Wang Q, Wu C, Yan H, Li X, Lu L, Wu C, Zhu D, Xu X, Wu J (2021) m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1. J Oncol 2021(8875424). https:\/\/doi.org\/10.1155\/2021\/8875424","DOI":"10.1155\/2021\/8875424"},{"issue":"1","key":"2461_CR35","doi-asserted-by":"publisher","first-page":"28279","DOI":"10.1038\/s41598-024-80057-2","volume":"14","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zhu Y, Guo F, Long H, Yin M (2024) Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinoma. Sci Rep 14(1):28279. https:\/\/doi.org\/10.1038\/s41598-024-80057-2","journal-title":"Sci Rep"},{"issue":"1","key":"2461_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00251-022-01275-4","volume":"75","author":"J Zhu","year":"2023","unstructured":"Zhu J, Li Y, Lv X (2023) IL4I1 enhances PD-L1 expression through JAK\/STAT signaling pathway in lung adenocarcinoma. Immunogenetics 75(1):17\u201325. https:\/\/doi.org\/10.1007\/s00251-022-01275-4","journal-title":"Immunogenetics"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02461-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02461-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02461-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:47:42Z","timestamp":1781578062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02461-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02461-9","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval is not required for this study in accordance with no human sample used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"138"}}